Dr Johan Luthman | Vice President Neuroscience Clinical Development
Eisai Medical Research
| Johan Luthman is VP Neuroscience Clinical Development, Eisai Pharmaceuticals, where he is engaged in clinical development programs, primarily in the area of Alzheimer’s disease. Before joining Eisai, Johan was Senior Program Leader for Early Development Neuroscience & Ophthalmology at Merck Research Laboratories, overseeing projects from preclinical candidate to proof of concept and Franchise Integrator, leading translational medicine and biomarker activities in neuroscience. Prior to Merck, Johan was Therapy Area Head of Neurology, Immunology & Inflammation Research and Head of PoC strategy in Neurology at MerckSerono. He joined Serono in 2005, as Head Neuroscience & Immunology Research. He also worked as CEO of GeNeuro during its build-up phase. Johan began his pharmaceutical career in 1991 in Astra. In Astra/AstraZeneca he worked as project leader as well as director of research departments, before leading Translational Science in Neurology & Analgesia. Johan studied medicine and dentistry at Karolinska Institute. In parallel with clinical practice, he obtained a Ph. D in neurobiology. He continued as a Research Fellow in Pharmacology & Psychiatry at the University of Colorado. Johan was subsequently appointed associate professor in Neurobiology at Karolinska and received an honorary professorship in pharmacology from the University of Chile. He obtained business training at SIMI, Copenhagen and Thunderbird and MIT/Sloan Management Institute. |
Organiser
